Clinical trial · Observational
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients With Hepatitis B Virus Infection
NCT02108444CI-TRIAL-00015194completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a retrospective analysis to explore the incidence of hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy, the efficacy and safety of chemotherapy, and overall survival rate in lymphoma patients with hepatitis B virus infection.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Diseases | — | UNRESOLVED | — |
| Hepatitis | — | UNRESOLVED | — |
| Hepatitis B | — | UNRESOLVED | — |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- group with HBV reactivation
- description
- group with hepatitis B virus reactivation
- label
- group without HBV reactivation
- description
- group without hepatitis B virus reactivation
Primary outcomes (1)
- measure
- the incidence of hepatitis B virus delayed reactivation
- timeFrame
- within one year after withdrawal of prophylactic antiviral therapy
- description
- hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy
Secondary outcomes (3)
- measure
- the incidence of hepatitis B virus related hepatitis flare
- timeFrame
- within one year after withdrawal of prophylactic antiviral therapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * treatment-naive patients with lymphoma * patients with a history of previous exposure to hepatitis B virus (HBV): HBsAg or hepatitis B core antibody (anti-HBc) positive Exclusion Criteria: * HBsAg and HBcAb negative
References
Publications (0)
Data not yet available
No reference posted for this study.